“…These include factors related to implant design, such as trunnion-taper angular mismatch, high-offset implants, trunnion diameter, neck angle, modular surface contact area, and dissimilar metals; patient factors, such as a high body mass index (BMI) or increased activity level; and surgical factors, such as damaged modular surfaces or inappropriate impaction forces [1][2][3][4] . Several authors have reported revision arthroplasty due to corrosion and adverse local tissue reactions 5,6 . Severe trunnion corrosion, or deterioration of the femoral neck, can also lead to femoral head dissociation and catastrophic and sudden implant failure following primary total hip arthroplasty.…”
“…These include factors related to implant design, such as trunnion-taper angular mismatch, high-offset implants, trunnion diameter, neck angle, modular surface contact area, and dissimilar metals; patient factors, such as a high body mass index (BMI) or increased activity level; and surgical factors, such as damaged modular surfaces or inappropriate impaction forces [1][2][3][4] . Several authors have reported revision arthroplasty due to corrosion and adverse local tissue reactions 5,6 . Severe trunnion corrosion, or deterioration of the femoral neck, can also lead to femoral head dissociation and catastrophic and sudden implant failure following primary total hip arthroplasty.…”
“…In a paper by Kirin et al, the authors postulate that the impaction of the femoral head or cyclic loading removes the oxide passivation layer creating crevices in the taper junction [6]. This allows for fluid ingress within the taper with depletion of oxygen and ionic changes ultimately leading to the formation of hydrochloric acid and resulting corrosion.…”
Background: Gross trunnion failure (GTF) after total hip arthroplasty is a rare complication and has only been reported in a few case series. Some of the associated risk factors have been described in the literature and include larger femoral heads, greater offset, and increased BMI. Despite this, the mechanism behind GTF is poorly understood and early diagnosis and treatment continues to be challenging.Case Presentation: We present the case of complete femoral head and trunnion dissociation in a 63 year-old female nine years after total hip arthroplasty. Unique to this case is the lack of classic patient and implant risk factors for GTF along with the acute onset nearly nine years after implantation.Discussion: This case presentation highlights the fact that the contributing factors and mechanism behind GTF continue to be poorly understood. There is a need for future research to help better understand this phenomenon and to help potentially identify those at risk for GTF.
“…При всех изученных заболеваниях суставов установлены нарушения микроэлементного состава крови, которые участвуют в патогенетических механизмах артритов и определяют их клиническое течение. Микроэлементоз рассматривается как одно из важных клинико-патогенетических составляющих дегенеративно-воспалительных болезней суставов [6,11,17].…”
Практична медицина / Practical Medicine Резюме. Актуальность работы. Микроэлементоз (дисбаланс в организме уровней отдельных микроэлементов-МЭ) рассматривается как одно из важных клинико-патогенетических составляющих дегенеративно-воспалительных болезней суставов, а МЭ могут играть роль кофакторов, участвующих в процессах артикулярного воспаления. Цель работы: изучить уровни в волосах и провести оценку клинико-патогенетической значимости остеоассоциированных МЭ (кобальта-Со, меди-Cu, железа-Fe, лития-Li, марганца-Mn, свинца-Pb, стронция-Sr, цинка-Zn) при различных артритахревматоидном (РА), реактивном урогенитальном хламидийиндуцированном (РеА), псориатическом (ПсА), подагрическом (ПА) и остеоартрите (ОА).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.